Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)
Consultation description
This consultation seeks your views on the reclassification from pharmacy (P) to general sale list (GSL) of Nurofen Express 400mg Oral Powder.
You are invited to comment on the proposal, a copy of which can be found above. A form for your reply is also attached.
Comments should be sent to Abiodun Aderogba at the MHRA Reclassification Unit.